Cargando…

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease

BACKGROUND: The SF-6D was derived from the SF-36. A single summary score is obtained allegedly preserving the descriptive richness and sensitivity to change of the SF-36 into utility measurement. We compared the SF-6D and EQ-5D on domain content, scoring distribution, pre-treatment and change scores...

Descripción completa

Detalles Bibliográficos
Autores principales: van Stel, Henk F, Buskens, Erik
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475841/
https://www.ncbi.nlm.nih.gov/pubmed/16563170
http://dx.doi.org/10.1186/1477-7525-4-20
_version_ 1782128154242973696
author van Stel, Henk F
Buskens, Erik
author_facet van Stel, Henk F
Buskens, Erik
author_sort van Stel, Henk F
collection PubMed
description BACKGROUND: The SF-6D was derived from the SF-36. A single summary score is obtained allegedly preserving the descriptive richness and sensitivity to change of the SF-36 into utility measurement. We compared the SF-6D and EQ-5D on domain content, scoring distribution, pre-treatment and change scores. METHODS: The SF-6D and the EQ-5D were completed prior to intervention and 1, 3, 6 and 12 months post-intervention in a study enrolling 561 patients with symptomatic coronary stenosis. Patients were randomized to off-pump coronary artery bypass surgery (CABG), standard on-pump CABG, or percutaneous transluminal coronary angioplasty (PTCA). Baseline and change over time scores were compared using parametric and non-parametric tests. RESULTS: The relative contribution of similar domains measuring daily functioning to the utility scores differed substantially. SF-6D focused more on social functioning, while EQ-5D gave more weight to physical functioning. Pain and mental health had similar contributions. The scoring range of the EQ-5D was twice the range of the SF-6D. Before treatment, EQ-5D and SF-6D mean scores appeared similar (0.64 versus 0.63, p = 0.09). Median scores, however, differed substantially (0.69 versus 0.60), a difference exceeding the minimal important difference of both instruments. Agreement was low, with an intra-class correlation of 0.45. Finally, we found large differences in measuring change over time. The SF-6D recorded greater intra-subject change in the PTCA-group. Only the EQ-5D recorded significant change in the CABG-groups. In the latter groups changes in SF-6D domains cancelled each other out. CONCLUSION: Although both instruments appear to measure similar constructs, the EQ-5D and SF-6D are quite different. The low agreement and the differences in median values, scoring range and sensitivity to change after intervention show that the EQ-5D and SF-6D yield incomparable scores in patients with coronary heart disease.
format Text
id pubmed-1475841
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14758412006-06-10 Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease van Stel, Henk F Buskens, Erik Health Qual Life Outcomes Research BACKGROUND: The SF-6D was derived from the SF-36. A single summary score is obtained allegedly preserving the descriptive richness and sensitivity to change of the SF-36 into utility measurement. We compared the SF-6D and EQ-5D on domain content, scoring distribution, pre-treatment and change scores. METHODS: The SF-6D and the EQ-5D were completed prior to intervention and 1, 3, 6 and 12 months post-intervention in a study enrolling 561 patients with symptomatic coronary stenosis. Patients were randomized to off-pump coronary artery bypass surgery (CABG), standard on-pump CABG, or percutaneous transluminal coronary angioplasty (PTCA). Baseline and change over time scores were compared using parametric and non-parametric tests. RESULTS: The relative contribution of similar domains measuring daily functioning to the utility scores differed substantially. SF-6D focused more on social functioning, while EQ-5D gave more weight to physical functioning. Pain and mental health had similar contributions. The scoring range of the EQ-5D was twice the range of the SF-6D. Before treatment, EQ-5D and SF-6D mean scores appeared similar (0.64 versus 0.63, p = 0.09). Median scores, however, differed substantially (0.69 versus 0.60), a difference exceeding the minimal important difference of both instruments. Agreement was low, with an intra-class correlation of 0.45. Finally, we found large differences in measuring change over time. The SF-6D recorded greater intra-subject change in the PTCA-group. Only the EQ-5D recorded significant change in the CABG-groups. In the latter groups changes in SF-6D domains cancelled each other out. CONCLUSION: Although both instruments appear to measure similar constructs, the EQ-5D and SF-6D are quite different. The low agreement and the differences in median values, scoring range and sensitivity to change after intervention show that the EQ-5D and SF-6D yield incomparable scores in patients with coronary heart disease. BioMed Central 2006-03-25 /pmc/articles/PMC1475841/ /pubmed/16563170 http://dx.doi.org/10.1186/1477-7525-4-20 Text en Copyright © 2006 van Stel and Buskens; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
van Stel, Henk F
Buskens, Erik
Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title_full Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title_fullStr Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title_full_unstemmed Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title_short Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
title_sort comparison of the sf-6d and the eq-5d in patients with coronary heart disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475841/
https://www.ncbi.nlm.nih.gov/pubmed/16563170
http://dx.doi.org/10.1186/1477-7525-4-20
work_keys_str_mv AT vanstelhenkf comparisonofthesf6dandtheeq5dinpatientswithcoronaryheartdisease
AT buskenserik comparisonofthesf6dandtheeq5dinpatientswithcoronaryheartdisease